Indivior Pharmaceuticals, Inc. INDV Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current)?
- Indivior Pharmaceuticals, Inc. (INDV) reported operating lease liabilities (current) of $9M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current) changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current) decreased by 18.2% year-over-year, from $11M to $9M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current)?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's operating lease liabilities (current) has grown at a 5.4% compound annual growth rate (CAGR), from $9M to $10M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.